ANTM - Anthem beats Q4 consensus Q4 top line up 16%

Anthem (ANTM) Q4 results:Revenues: $31.53B (+16.2%); Commercial & Specialty Business: $9.22B (-1.1%); Government Business: $18.76B (+15.7%); IngenioRx: $5.86B (+81.4%).Net Income: $551M (-41%); EPS: $2.19 (-39.5%); non-GAAP Net Income: $637M (-36.3%); non-GAAP EPS: $2.54 (-34.5%).CF Ops: $3.8B (+$2.5B).Total Medical Membership: 42.93M (+4.7%); Self-Funded Medical Membership: 25.63M (+0.8%); Fully-Insured Medical Membership: 17.296M (+11%).Benefit Expense Ratio: 88.9%, a decrease of 10 bps from 89% in Q4 2019.2020 Guidance: GAAP EPS: >$23.51 per share; Non-GAAP EPS: >$24.50 per share (unch).Previously (Jan 27): Anthem EPS beats by $0.01, beats on revenue

For further details see:

Anthem beats Q4 consensus, Q4 top line up 16%